Filing Details

Accession Number:
0001127602-14-017015
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-09 16:55:05
Reporting Period:
2014-05-08
Filing Date:
2014-05-09
Accepted Time:
2014-05-09 16:55:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1100682 Charles River Laboratories International Inc CRL Services-Commercial Physical & Biological Research (8731) 061397316
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1221496 George Massaro 251 Ballardvale Street
Wilmington MA 01887
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-05-08 100 $52.12 18,030 No 4 S Direct
Common Stock Disposition 2014-05-08 100 $52.28 17,930 No 4 S Direct
Common Stock Disposition 2014-05-08 120 $52.38 17,810 No 4 S Direct
Common Stock Disposition 2014-05-08 100 $52.48 17,710 No 4 S Direct
Common Stock Disposition 2014-05-08 100 $52.50 17,610 No 4 S Direct
Common Stock Disposition 2014-05-08 100 $52.57 17,510 No 4 S Direct
Common Stock Disposition 2014-05-08 100 $52.60 17,410 No 4 S Direct
Common Stock Disposition 2014-05-08 100 $52.62 17,310 No 4 S Direct
Common Stock Disposition 2014-05-08 100 $52.80 17,210 No 4 S Direct
Common Stock Disposition 2014-05-08 100 $52.87 17,110 No 4 S Direct
Common Stock Disposition 2014-05-08 100 $52.99 17,010 No 4 S Direct
Common Stock Disposition 2014-05-08 100 $53.03 16,910 No 4 S Direct
Common Stock Disposition 2014-05-08 100 $53.09 16,810 No 4 S Direct
Common Stock Disposition 2014-05-08 200 $53.10 16,610 No 4 S Direct
Common Stock Disposition 2014-05-08 100 $52.66 16,510 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. This sale occured pursuant to a 10b5-1 Trading Plan.